Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.

Cuilv LiangYin ZhangQi Ying ChenWen Fa ChenMing Zhu Chen

Published in: Asia-Pacific journal of clinical oncology (2023)

Cumulative dose, BMI, BSA, and hypocalcemia are all risk factors for overall TIPN, whereas cumulative dose and BSA are risk factors for moderate-severe TIPN. Patients with breast cancer who have high BMI, large BSA, hypocalcemia, and large cumulative dose may be at risk of TIPN, and intervention measures must be actively carried out for them.

Keyphrases

body mass index
randomized controlled trial
weight gain
drug induced
early onset
diabetic rats
high intensity
physical activity
weight loss